Photo: India Today
Expert Panel Suggests Covaxin For Children Between 2 To 18 Years
Covaxin, Bharat Biotech's COVID-19 vaccine, was recommended by an expert panel on October 12 for use on children aged two to 18. The company has also received a positive response from the Central Drugs Standard Control Organisation (CDSCO) on its clinical trials. Reportedly, children received the same vaccination as adults in separate trials. However, the company is waiting to get the regulatory approvals to launch it in the market.
Tags: Covid-19, Covid Vaccine, Covaxin, children
Courtesy: NDTV
Photo: The Indian Express
India Starts Export of COVID-19 Vaccine, Supplies 4 Countries
Under the ''Vaccine Maitri'' initiative, India started the export of vaccine doses to Myanmar, Nepal, Bangladesh, and Iran, media reports said on October 10. Repotedly, India sent 10 lakh doses of Covidsheild to Myanmar, Nepal, and Bangladesh. While Iran will receive three lakh doses of Covaxin. The initiative will also help India to fulfill its commitment towards COVAX to supply vaccine to poor countries.
Tags: Covid Vaccine, vaccine, Export, India
Courtesy: ANI
Photo: The Economic Times
WHO Expert Panel To Meet, Evaluate Covaxin EUL
The World Health Organization (WHO) has not yet granted Covaxin emergency use Authorization. It is India's domestically produced coronavirus vaccine. On October 5, the Strategic Advisory Group of Experts on Immunization (SAGE) will have a meeting to discuss the Emergency Use Listing (EUL) for Covaxin. The four-day meeting of the expert group to deliberate on policy recommendations began on October 4. Only six vaccine candidates have been… read-more
Tags: WHO, Covid-19, Covid Vaccine, Covaxin
Courtesy: Hindustan Times
Photo: News18
CoWIN Portal: Now Download International Version Of Vaccination Certificate
The latest section of the CoWIN website termed "International Travel Certificate" will now have the international version of the Covid-19 vaccination certificate. The international travel certificate will cover: registered date of birth, the number of doses received, vaccine name, type, manufacturer, and dosage dates. The certificate complies with the international criteria set out by the World Health Organization. The international… read-more
Tags: CoWIN App, Covid Vaccine, Coronavirus Vaccine Certificate, India
Courtesy: Republic World
Photo: Indian Express
New Covid-19 Strains Might Develop Due To Vaccine Stockpiling: Leaders At UN
Despite the fact that diseases are already on the rise in many regions, leaders from developing countries informed the United Nations General Assembly that affluent countries' COVID-19 vaccine stockpiling might develop new coronavirus strains. The Philippines has warned of a man-made vaccination shortage in poor nations. Peru said that international unity had failed, while Ghana condemned vaccine sovereignty. The unequal distribution of COVID… read-more
Tags: Covid-19, Covid Vaccine, United Nations, hoarding vaccine
Courtesy: Reuters
Photo: Unicef
Central Govt Resumes To Export COVID-19 Vaccines; WHO Upvotes India
Indian Health Minister Mansukh Mandaviya, on September 20, announced that the Government has decided to re-initiate the export of COVID vaccines. Reportedly, WHO Chief Tedros Adhanom Ghebreyesus thanked India and called it an "Important Development" that is crucial for ensuring Vaccine equality across the globe. Earlier, owing to the deadly second wave COVID, India in April 2021, had to stop the shipments of vaccines.
Tags: Covid-19, Covid Vaccine, WHO, Health Ministry
Courtesy: The Hindu
Photo: The Economic Times
WHO Postpones Covaxin Approval To Oct 5: Covid-19
The approval for Emergency Use Authorisation (EUA) of Covaxin, manufactured by Hyderabad-based Bharat Biotech, is now postponed to October 5, by World Health Organization (WHO). WHO's Strategic Advisory Group on Immunization is scheduled to meet on October 5 to grant Covaxin the EUA. A vaccination safety monitoring strategy will be updated on a global, regional, and national level. EUA will be proposed based on Covaxin's trials.
Tags: Covaxin, Covid-19, Covid Vaccine, WHO, Bharat biotech
Courtesy: NDTV
Photo: BioSpectrum Asia
SII To Boost Covishield Production To 200 Million Doses From Oct
CEO of Serum Institute of India (SII), Adar Poonawalla addressed a virtual conference with Executive Chairperson of Biocon Biologics (BBL) Kiran Mazumdar Shaw to announce their strategic alliance on September 17. Reportedly, SII was looking to scale up its research facilities with BBL. Also, the alliance aims to increase the production of Covishield Vaccines from 160 million doses monthly to 200 million doses from October.
Tags: Covid-19, COVISHIELD, SII, Covid Vaccine, Biocon Biologics, Adar Poonawalla
Courtesy: The Indian Express
Photo: The Print
India Celebrates PM Modi's Birthday; Over 2.5 Cr Vaccines Administered
Almost 2,50,10,390 vaccination shots have been administered on September 17, PM Modi's birthday. It was the highest since May 2021. With this feat, India has vaccinated about 63% of its adult population, and 30% of people are fully vaccinated. Mostly BJP ruled states like Karnataka, Bihar, UP, MP, and Gujarat administered 20 lakh doses each. PM Modi tweeted to… read-more
Tags: Covid -19, PM Narendra Modi, Vaccination Drive, Covid Vaccine
Courtesy: The Indian Express
Photo: The Free Press Journal
COVID-19 Pandemic May Turn To Endemic In 6 months: NCDC Director
Expert Sujeet Singh, Director of the National Centre for Disease Control (NCDC) said, the pandemic may turn to an endemic in the next six months. Endemicity means infection would become more manageable. The new emerging variants like C1.2 and Mu cannot alone bring the third wave. He stressed on vaccinating more people currently, 75 crore Indians are jabbed, and people must follow Covid appropriate behavior.
Tags: Covid-19, Health Body Chief, Sujeet Singh, Covid Vaccine
Courtesy: NDTV
